To explore the application value of contrast-enhanced ultr
asound (CEUS) in adjusting the Ovarian- Adnexal Reporting and Data System (O-RADS) grading for ovarian adnexal masses.
Methods:
A total of 98 patients in Shanghai General Hospital
Shanghai Jiao Tong University School of Medicine with ovarian adnexal masses who underwent two-dimensional ultrasound and CEUS examinations were selected as the study subjects. The two-dimensional ultrasound images were evaluated through O-RADS and CEUS perfusion characteristics were analyzed. With pathological diagnosis as the gold standard
the receiver operating characteristic (ROC) curve was drew
and the diagnostic efficacy of O-RADS and O-RADS+CEUS in ovarian accessory malignant tumors were analyzed.
Results:
The pathological results showed 25 cases of malignant masses and 73 cases of benign masses. The proportion of malignant masses with cyst wall/septal thickness ≥3 cm
solid components
papillary protrusions≥4
blood flow score 3-4
and ascites were 68.00%
80.00%
24.00%
60.00%
and 60.00%
respectively
which were significantly higher than those of benign masses with 8.22%
27.40%
5.48%
4.11%
and 5.48%
all
P
<0.05. In terms of CEUS signs
benign masses mainly exhibit uniform enhancement of no/low/equal
and slow/synchronous enhancement; Malignant masses are mainly characterized by uneven high enhancement and rapid enhancement. The ROC curve showed that the area under curve (AUC) value of O-RADS+CEUS in diagnosing ovarian adnexal malignant masses was higher than that of O-RADS (0.972 vs 0.860
P
<0.05). Compared with O-RADS
O-RADS+CEUS has significantly higher sensitivity
specificity
positive predictive value
negative predictive value
and accuracy in diagnosing ovarian adnexal malignant masses
and they were 95.03%
96.78%
92.02%
96.84%
and 96.17% respectively (
P
<0.05). Two ultrasound physicians had high consistency in evaluating the O-RADS classification results of grayscale ultrasound and grayscale ultrasound+CEUS (Kappa=0.885
0.871).
Conclusion:
Ultrasound O-RADS classification can accurately determine the risk stratification of ovarian adnexal masses. The addition of CEUS can adjust the O-RADS grading